Long-Acting Injectable Second-Generation Antipsychotics Improve Negative Symptoms and Suicidal Ideation in Recent Diagnosed Schizophrenia Patients: A 1-Year Follow-up Pilot Study

Table 2

Mean changes in clinical and psychosocial features from baseline to 12-month follow-up in recent schizophrenia and in long-term schizophrenia patients.

	Recent SZ (n=10)	Long-term SZ (n=15)
	Mean T0 (SD)/Mean T1 (SD)	Mean T0 (SD)/Mean T1 (SD)
GAF	43.6 (7.8)/56.4 (9.5)	40.1 (11.3)/49.0 (7.5)
PANSS Pos	9.2 (4.6)/6.8 (3.8)	11.5 (4.5)/6.6 (2.5)
PANSS Neg	13.7 (6.7)/11.5 (5.1)	16.7 (6.6)/15.1(5.0)
PANSS Dis/Con	7.0 (1.8)/5.8 (1.8)	7.9 (2.8)/6.9 (2.6)
PANSS Exc	8.2 (3.8)/5.0 (1.9)	9.3 (5.4)/5.5 (2.4)
PANSS Dep	6.8 (3.7)/5.8 (2.6)	6.1 (3.4)/5.5 (2.9)
IS severity	1.9 (2.3)/0.5 (1.6)	1.13 (2.1)/0.5 (1.8)
IS intensity	6.8 (8.4)/1.2 (3.8)	3.9 (7.1)/2.5 (5.5)
RSQ	21.2 (6.1)/23.4 (6.6)	22.4 (3.9)/23.6 (5.1)
Social cognition	80.6 (8.0)/83.5 (14.9)	81.9 (12.1)/84.3 (8.4)

=p<0.05; =p<0.001.